Simulating Outcomes From Breast Conserving Surgery Using 3D Surface Imaging
The Use of 3D Surface Imaging to Simulate Outcome After Breast Conserving Therapy
1 other identifier
interventional
117
1 country
1
Brief Summary
Most women with breast cancer are able to have an operation to remove the cancer while preserving the breast (breast conserving therapy, BCT). Whilst cancer control is the most important goal, appearance of the breast after surgery has been shown to affect the quality of a woman's life after treatment. This is even more relevant now that most women are surviving breast cancer. Before surgery, women are prepared for how they will look afterwards by having a discussion with the Surgeon or Breast Care Nurse. Sometimes women are shown two dimensional (2D) (standard) photographs of other women who had a similar operation. Patients have stated that viewing photographs of other patients does not prepare them adequately for their own experience of surgery. Three dimensional (3D) digital photography is currently being used to predict the appearance of the breasts after enlargement surgery using specialist software. The investigators intend to use a similar system to simulate a patient's appearance after BCT for cancer. The investigators believe that this will lead women to feel better prepared for their surgery, reduce stress, and lead to greater satisfaction with their breast after treatment. This study invites women undergoing BCT to be assigned at random to one of three groups receiving standard care (discussion), a 2D photograph, or the 3D simulation before their operation. The investigators will find out whether women feel better prepared for surgery and are more satisfied with their outcome if they are shown a simulated image of how their own breasts are likely to look. By taking 3D photographs of all study patients before and after surgery, a more accurate way to predict appearance after surgery will be developed for future patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2017
CompletedFirst Submitted
Initial submission to the registry
June 15, 2017
CompletedFirst Posted
Study publicly available on registry
August 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedAugust 15, 2017
July 1, 2017
1.7 years
June 15, 2017
August 10, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The difference between groups in the mean pre-operative Visual Analogue Scale.
The mean VAS score (range: 0 -10mm) will be compared between groups. It is intended to assess preparedness for surgery of the women in each of the three arms. Patient scores in answer to the question "How confident are you that you know how your breasts are likely to look after treatment?" will be measured for each patient following randomisation and completion of their pre-operative preparation depending on study group.
preoperatively
Secondary Outcomes (3)
The differences in post-operative 'Satisfaction with Information' scores between the 3 groups
preoperatively , 3 months and 12 months
The difference in 'satisfaction with breasts' score pre and post-operatively between the 3 groups.
preoperatively , 3 months and 12 months
The difference in 'Quality of Life' score pre and post-operatively between the 3 groups.
preoperatively , 3 months and 12 months
Other Outcomes (9)
The difference in post-operative VAS score between groups.
3 months and 12 months
The differences in linear mammometrics between 3D-Simulation and post operative reality
3 months and 12 months
The differences in volume measurement between 3D-Simulation and post operative reality
3 months and 12 months
- +6 more other outcomes
Study Arms (3)
Standard Care
NO INTERVENTIONPatient receives standard pre-operative preparation which involves a discussion in to the likely aesthetic outcome with their surgeon or specialist nurse
2-dimensional Portfolio
EXPERIMENTALPatient views photographs of women matched for BMI, age, and breast volume who are 1-5 years post BCT pre-operatively.
3-dimensional simulation
EXPERIMENTALPatient pre-operatively views a simulation of their own breast of their likely outcome after BCT.
Interventions
The viewing of a 3-dimensional simulation is classed as an intervention as it strays from the normal pre-operative preparation.
The viewing of a 2-dimensional photograph library is classed as an intervention as it strays from the normal pre-operative preparation.
Eligibility Criteria
You may qualify if:
- Female patients Over 18 years Planned for unilateral breast conserving surgery at RMH Planned to receive adjuvant whole breast radiotherapy at RMH Willing to attend for study follow up visits.
You may not qualify if:
- Previous or concurrent surgery to the contralateral breast (previous breast conserving surgery, breast reduction or mastectomy)
- Previous surgery to the ipsilateral breast
- Unable to stand for long enough to have clinical photos (approximately 5 minutes)
- Unable to answer the BREAST-Q questionnaire (e.g. learning difficulties)
- Visually impaired (so that they could not view a 2D/3D images)
- Pre-operatively planning to have a symmetrisation procedure after radiotherapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Marsden Hospital
Sutton, Surrey, sm25pt, United Kingdom
Related Publications (1)
Godden AR, Micha A, Wolf LM, Pitches C, Barry PA, Khan AA, Krupa KDC, Kirby AM, Rusby JE. Three-dimensional simulation of aesthetic outcome from breast-conserving surgery compared with viewing photographs or standard care: randomized clinical trial. Br J Surg. 2021 Oct 23;108(10):1181-1188. doi: 10.1093/bjs/znab217.
PMID: 34370833DERIVED
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2017
First Posted
August 15, 2017
Study Start
May 1, 2017
Primary Completion
December 31, 2018
Study Completion
December 31, 2023
Last Updated
August 15, 2017
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will not share